Marinus plans to conduct $35 million at-the-market offering of stock

Agent JMP Securities will be paid a 3% commission for equity sales

By Devika Patel

Knoxville, Tenn., Aug. 13 – Marinus Pharmaceuticals, Inc. negotiated a $35 million at-the-market equity distribution agreement with JMP Securities LLC on Aug. 13, according to an 8-K and prospectus supplement filed Thursday with the Securities and Exchange Commission.

The agent will be paid a 3% commission.

The biopharmaceutical company is based in New Haven, Conn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.